This section of the site includes press releases and statements issued by the MHRA.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
151 Buckingham Palace Road
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.
Press enquiries should be made through the Press Office.
Latest press releases
17 Oct 2014 | Press release: Regulator warns dentists about the dangers of buying and using counterfeit and unapproved dental equipment
The Medicines and Healthcare products Regulatory Agency (MHRA) is warning dentists about the potential danger of buying and using counterfeit and unapproved dental equipment. This follows the seizure of over 12,000 different pieces of poor quality dental equipment imported into the UK from China and Pakistan and sold on auction websites such as eBay, Amazon and Alibaba in the past 6 months.
17 Oct 2014 | MHRA statement on misuse of laxatives
MHRA has issued a statement following the BBC Watchdog investigation into the availability of stimulant laxatives in the UK, first broadcast on Thursday 16 October.
13 Oct 2014 | Press release: ‘One stop shop’ for advice on regenerative medicine opening for business
A new ‘one stop shop’ that will provide regulatory advice for those working in the life sciences industry on exciting regenerative medicines has been launched today.
10 Oct 2014 | Press release: MHRA responds to European Medicines Agency recommendations on the use of valproate medicines
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended strengthening the restrictions on the use of valproate medicines due to an increased risk of birth defects and developmental problems in children exposed to valproate in the womb.
The National Institute for Biological Standards and Control (NIBSC), a centre of the Medicines and Healthcare Products Regulatory Agency (MHRA), has signed an agreement with University College London (UCL) to maximise and further promote scientific collaboration in the field of advanced therapies.
25 Sep 2014 | Press release: New guidance on reporting suspected adverse drug reactions in children and neonates
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced new simplified guidance for healthcare professionals reporting suspected adverse drug reactions (ADRs) in children to its Yellow Card Scheme.
05 Sep 2014 | Press release: UK regulator leads innovative EU project on the use of smartphones and social media for drug safety information
The Medicines and Healthcare products Regulatory Agency (MHRA) is leading a consortium of organisations including European medicines regulators, academics and the pharmaceutical industry in a three year project to develop new ways of gathering information on suspected adverse drug reactions (ADRs).
From 4 September 2014, people taking domperidone to treat nausea and vomiting will only be able to get this medicine on prescription from their doctor.
The 150th Anniversary Edition of the British Pharmacopoeia (BP) has been published today. The BP is the authoritative collection of medicinal standards used and referenced in over 100 countries. With the first edition of the BP published in 1864 and the origins of the BP extending back to 1618 the publication of the 150th Anniversary Edition represents a milestone in the history and development of quality standards for pharmaceuticals.
15 Aug 2014 | Press release: London man sentenced to 16 weeks for repeatedly selling dangerous super-strength ‘herbal’ erection drug
A 58-year-old man has today been sentenced to 16 weeks in prison at Wood Green Crown Court for the sale and supply of a potent, unlicensed erection dysfunction medicine containing four times the maximum dose of tadalafil, the active ingredient in the prescription-only medicine Cialis.